Primal Therapies
Boise, US · Founded 2012 · Delaware corporation
Find your way into Primal Therapies
Sign up to see every warm intro you have to Primal Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Primal Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Primal Health makes consumable oral care products that use its patented SMMRT Science, combining microbiology and molecular nutrition to balance the oral microbiome in both people and pets. Its products are sold direct-to-consumer and are backed by clinical studies on gum health and harmful bacteria reduction.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$677K disclosed across 1 round · 2016
▶$677KraisedOct 2016 · 8 investors · BiotechnologyRule 506(b)
- Terry FademDirector
- David EigenDirector
- Emily SteinExecutive Officer, Director
- Michael O'DonnellExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $677K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $206.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Primal Therapies do?
- Primal Health makes consumable oral care products that use its patented SMMRT Science, combining microbiology and molecular nutrition to balance the oral microbiome in both people and pets. Its products are sold direct-to-consumer and are backed by clinical studies on gum health and harmful bacteria reduction.
- How much funding has Primal Therapies raised?
- Primal Therapies has disclosed $677K raised across 1 round.
- Where is Primal Therapies headquartered?
- Primal Therapies is headquartered in Boise, US.
